These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 11919484)

  • 1. Neutralizing antibodies as a potential secondary protective mechanism during chronic SHIV infection in CD8+ T-cell-depleted macaques.
    Rasmussen RA; Hofmann-Lehmann R; Li PL; Vlasak J; Schmitz JE; Reimann KA; Kuroda MJ; Letvin NL; Montefiori DC; McClure HM; Ruprecht RM
    AIDS; 2002 Apr; 16(6):829-38. PubMed ID: 11919484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early antibody therapy can induce long-lasting immunity to SHIV.
    Nishimura Y; Gautam R; Chun TW; Sadjadpour R; Foulds KE; Shingai M; Klein F; Gazumyan A; Golijanin J; Donaldson M; Donau OK; Plishka RJ; Buckler-White A; Seaman MS; Lifson JD; Koup RA; Fauci AS; Nussenzweig MC; Martin MA
    Nature; 2017 Mar; 543(7646):559-563. PubMed ID: 28289286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-Follicular-Like CD8
    Romero-Martín L; Tarrés-Freixas F; Pedreño-López N; Rodríguez de la Concepción ML; Cunyat F; Hartigan-O'Connor D; Carrillo J; Mothe B; Blanco J; Ruiz-Riol M; Brander C; Olvera A
    Front Immunol; 2022; 13():928039. PubMed ID: 35784304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery from acute SARS-CoV-2 infection and development of anamnestic immune responses in T cell-depleted rhesus macaques.
    Hasenkrug KJ; Feldmann F; Myers L; Santiago ML; Guo K; Barrett BS; Mickens KL; Carmody A; Okumura A; Rao D; Collins MM; Messer RJ; Lovaglio J; Shaia C; Rosenke R; van Doremalen N; Clancy C; Saturday G; Hanley P; Smith B; Meade-White K; Shupert WL; Hawman DW; Feldmann H
    bioRxiv; 2021 Apr; ():. PubMed ID: 33821272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection.
    Huang KH; Bonsall D; Katzourakis A; Thomson EC; Fidler SJ; Main J; Muir D; Weber JN; Frater AJ; Phillips RE; Pybus OG; Goulder PJ; McClure MO; Cooke GS; Klenerman P
    Nat Commun; 2010 Oct; 1():102. PubMed ID: 20981030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV.
    Kelschenbach JL; Saini M; Hadas E; Gu CJ; Chao W; Bentsman G; Hong JP; Hanke T; Sharer LR; Potash MJ; Volsky DJ
    J Neuroimmune Pharmacol; 2012 Jun; 7(2):380-7. PubMed ID: 21987348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the breadth of neutralizing antibody response in cats naturally infected with feline immunodeficiency virus.
    Bęczkowski PM; Logan N; McMonagle E; Litster A; Willett BJ; Hosie MJ
    J Gen Virol; 2015 Mar; 96(Pt 3):671-680. PubMed ID: 25395594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous and endogenous hyaluronic acid reduces HIV infection of CD4(+) T cells.
    Li P; Fujimoto K; Bourguingnon L; Yukl S; Deeks S; Wong JK
    Immunol Cell Biol; 2014 Oct; 92(9):770-80. PubMed ID: 24957217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level, lasting antiviral immunity induced by a bimodal AIDS vaccine and boosted by live-virus exposure: prevention of viremia.
    Rasmussen RA; Siddappa NB; Lakhashe SK; Watkins J; Villinger F; Ibegbu C; Florese RH; Robert-Guroff M; Montefiori DC; Forthal DN; O'Connor D; Ruprecht RM;
    AIDS; 2012 Jan; 26(2):149-55. PubMed ID: 21941166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bimodal AIDS vaccine approach: induction of cellular as well as humoral immunity can protect from systemic infection.
    Rasmussen RA; Lakhashe SK; Ruprecht RM
    Vaccine; 2010 May; 28 Suppl 2(0 2):B25-31. PubMed ID: 20510739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental depletion of CD8+ cells in acutely SIVagm-infected African Green Monkeys results in increased viral replication.
    Gaufin T; Ribeiro RM; Gautam R; Dufour J; Mandell D; Apetrei C; Pandrea I
    Retrovirology; 2010 May; 7():42. PubMed ID: 20459829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of disulfide-stabilized structure on the specificity of helper T-cell and antibody responses to HIV envelope glycoprotein gp120.
    Mirano-Bascos D; Steede NK; Robinson JE; Landry SJ
    J Virol; 2010 Apr; 84(7):3303-11. PubMed ID: 20089653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ cell depletion of SHIV89.6P-infected macaques induces CD4+ T cell proliferation that contributes to increased viral loads.
    Mueller YM; Do DH; Boyer JD; Kader M; Mattapallil JJ; Lewis MG; Weiner DB; Katsikis PD
    J Immunol; 2009 Oct; 183(8):5006-12. PubMed ID: 19786539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine.
    Haut LH; Ertl HC
    J Leukoc Biol; 2009 Oct; 86(4):779-93. PubMed ID: 19597003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120.
    Mirano-Bascos D; Tary-Lehmann M; Landry SJ
    Eur J Immunol; 2008 May; 38(5):1231-7. PubMed ID: 18398933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys.
    Veazey RS; Acierno PM; McEvers KJ; Baumeister SH; Foster GJ; Rett MD; Newberg MH; Kuroda MJ; Williams K; Kim EY; Wolinsky SM; Rieber EP; Piatak M; Lifson JD; Montefiori DC; Brown CR; Hirsch VM; Schmitz JE
    J Virol; 2008 Jun; 82(11):5618-30. PubMed ID: 18367534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses.
    Li Y; Cleveland B; Klots I; Travis B; Richardson BA; Anderson D; Montefiori D; Polacino P; Hu SL
    J Virol; 2008 Jan; 82(2):638-51. PubMed ID: 17959660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous CD4/CD8 co-culture assay: a physiologically-relevant composite measure of CD8+ T lymphocyte function in HIV-infected persons.
    Fauce SR; Yang OO; Effros RB
    J Immunol Methods; 2007 Oct; 327(1-2):75-81. PubMed ID: 17716683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters.
    Azizi A; Anderson DE; Ghorbani M; Gee K; Diaz-Mitoma F
    BMC Immunol; 2006 Oct; 7():25. PubMed ID: 17076905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques.
    Schmitz JE; Johnson RP; McClure HM; Manson KH; Wyand MS; Kuroda MJ; Lifton MA; Khunkhun RS; McEvers KJ; Gillis J; Piatak M; Lifson JD; Grosschupff G; Racz P; Tenner-Racz K; Rieber EP; Kuus-Reichel K; Gelman RS; Letvin NL; Montefiori DC; Ruprecht RM; Desrosiers RC; Reimann KA
    J Virol; 2005 Jul; 79(13):8131-41. PubMed ID: 15956558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.